Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: Results from an 18-month proof-of-concept open-label randomized study

Journal of Diabetes and its Complications

Volumn 29, Issue 8, 2015, Pages 1287-1294

  Jaiswal, Mamta ^a   Martin, Catherine L ^a   Brown, Morton B ^b   Callaghan, Brian ^a   Albers, James W ^a   Feldman, Eva L ^a   Pop Busui, Rodica ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular autonomic neuropathy; Clinical trial; Diabetic peripheral neuropathy; Exenatide; Glargine; GLP 1receptor agonist

Indexed keywords

CAPSAICIN; CREATININE; EXENDIN 4; HEMOGLOBIN A1C; INSULIN GLARGINE; TRIACYLGLYCEROL LIPASE; ANTIDIABETIC AGENT; GLP1R PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INCRETIN; PEPTIDE; VENOM;

ABDOMINAL WALL HERNIA; ADULT; ARTICLE; ASTHMA; ASTHMATIC STATE; ATRIAL FIBRILLATION; AUTONOMIC NEUROPATHY; BACKACHE; BASAL CELL CARCINOMA; BILATERAL ANKLE CELLULITIS; BRONCHITIS; CELLULITIS; CERVICAL SPINE FRACTURE; CHOLELITHIASIS; CLINICAL ARTICLE; COHORT ANALYSIS; COLD; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIABETIC NEUROPATHY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DIVERTICULITIS; DIZZINESS; DRUG EFFECT; EAR INFECTION; EPIGASTRIC PAIN; FEMALE; FEVER; FIBROSING ALVEOLITIS; FINGER INJURY; FINGER LACERATION; FOLLOW UP; FOOT EDEMA; FOOT FRACTURE; GANGLION CYST; GLYCEMIC CONTROL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; HYPOTHYROIDISM; KNEE PAIN; LACERATION; LEG FRACTURE; LUNG EMBOLISM; MALE; NAUSEA; NEPHROLITHIASIS; NEUROENDOCRINE TUMOR; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPEN STUDY; PILOT STUDY; PLANTAR FASCIITIS; PLANTAR ULCER; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESTING HEART RATE; SIDE EFFECT; SINUSITIS; SKIN INFECTION; SOFT TISSUE INFECTION; SQUAMOUS CELL CARCINOMA; STREPTOCOCCAL PHARYNGITIS; THALASSEMIA; THORAX PAIN; TOOTH INFECTION; TREATMENT DURATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WRIST FRACTURE; AGED; AGONISTS; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DRUG EFFECTS; HYPERGLYCEMIA; METABOLISM; MICHIGAN; MIDDLE AGED; NERVE CONDUCTION; PATHOPHYSIOLOGY; PREVALENCE; SEVERITY OF ILLNESS INDEX;

AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INCRETINS; INSULIN GLARGINE; MALE; MICHIGAN; MIDDLE AGED; NEURAL CONDUCTION; PEPTIDES; PILOT PROJECTS; PREVALENCE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; VENOMS;

EID: 84948717486     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.07.013     Document Type: Article

References (38)

1. J.W. Albers, W.H. Herman, R. Pop-Busui, E.L. Feldman, C.L. Martin, P.A. Cleary, and et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Diabetes Care 33 2010 1090 1096
2. J.W. Albers, and R. Pop-Busui Diabetic neuropathy: Mechanisms, emerging treatments, and subtypes Current Neurology and Neuroscience Reports 14 2014 473 484
3. L. Ang, M. Jaiswal, C. Martin, and R. Pop-Busui Glucose control and diabetic neuropathy: Lessons from recent large clinical trials Current Diabetes Reports 14 2014 528 543
4. L.L. Baggio, Q. Huang, T.J. Brown, and D.J. Drucker A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis Diabetes 53 2004 2492 2500
5. J.I. Barros, F.V. Fechine, R.M. Montenegro Junior, O.C. do Vale, V.O. Fernandes, M.H. de Souza, and et al. Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus Arquivos Brasileiros de Endocrinologia e Metabologia 58 2014 369 376
6. A.E. Bharucha, N. Charkoudian, C.N. Andrews, M. Camilleri, D. Sletten, A.R. Zinsmeister, and et al. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 295 2008 R874 R880
7. M. Brod, D. Cobden, M. Lammert, D. Bushnell, and P. Raskin Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: Lessons learned from a clinical trial comparing biphasic and basal analogues Health and Quality of Life Outcomes 5 2007 8
8. B. Callaghan, and E. Feldman The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities Annals of Neurology 74 3 2013 397 403
9. B.C. Callaghan, A.A. Little, E.L. Feldman, and R.A. Hughes Enhanced glucose control for preventing and treating diabetic neuropathy Cochrane Database of Systematic Reviews 6 2012 CD007543 7601
10. W.T. Cefalu, J.B. Buse, S. Del Prato, P.D. Home, H.D. LeRoit, M.A. Nauck, and et al. Beyond metformin: Safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum Diabetes Care 37 2014 2647 2659
11. Q. Cheng, S. Yang, C. Zhao, Z. Wang, Z. Feng, R. Li, and et al. Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy Journal of Diabetes 7 2 2015 182 191
12. DCCT The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group New England Journal of Medicine 329 1993 977 986
13. DCCT Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial Annals of Neurology 38 1995 869 880
14. DCCT The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) Diabetologia 41 1998 416 423
15. D.J. Drucker, S.I. Sherman, R.M. Bergenstal, and J.B. Buse The safety of incretin-based therapies - Review of the scientific evidence Journal of Clinical Endocrinology and Metabolism 96 2011 2027 2031
16. P.J. Dyck, J.W. Albers, H. Andersen, J.C. Arezzo, G.J. Biessels, V. Bril, and et al. Diabetic polyneuropathies: Update on research definition, diagnostic criteria and estimation of severity Diabetes/Metabolism Research and Reviews 27 7 2011 620 628
17. E.L. Feldman, M.J. Stevens, P.K. Thomas, M.B. Brown, N. Canal, and D.A. Greene A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 17 1994 1281 1289
18. K.J. Griffioen, R. Wan, E. Okun, X. Wang, M.R. Lovett-Barr, Y. Li, and et al. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons Cardiovascular Research 89 2011 72 78
19. T. Himeno, H. Kamiya, K. Naruse, N. Harada, N. Ozaki, Y. Seino, and et al. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice Diabetes 60 9 2011 2397 2406
20. C.G. Jolivalt, M. Fineman, C.F. Deacon, R.D. Carr, and N.A. Calcutt GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice Diabetes, Obesity & Metabolism 13 11 2011 990 1000
21. M. Kan, G. Guo, B. Singh, V. Singh, and D.W. Zochodne Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy Journal of Neuropathology and Experimental Neurology 71 2012 494 510
22. M. Kondo, H. Kamiya, T. Himeno, K. Naruse, E. Nakashima, A. Watarai, and et al. Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes Journal of Diabetes Investigation 6 2 2015 140 149
23. S. Lam Insulin glargine: A new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus Heart Disease 5 3 2003 231 240
24. P. Luciani, C. Deledda, S. Benvenuti, I. Cellai, R. Squecco, M. Monici, and et al. Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model Cellular and Molecular Life Sciences: CMLS 67 2010 3711 3723
25. C.L. Martin, J.W. Albers, and R. Pop-Busui Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study Diabetes Care 37 2014 31 38
26. C.L. Martin, B.H. Waberski, R. Pop-Busui, P.A. Cleary, S. Catton, J.W. Albers, and et al. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: Results from the DCCT/EDIC study Diabetes Care 33 2010 2635 2641
27. P.L. McCormack Exenatide twice daily: A review of its use in the management of patients with type 2 diabetes mellitus Drugs 74 2014 325 351
28. T. Okawa, H. Kamiya, T. Himeno, Y. Seino, S. Tsunekawa, Y. Hayashi, and et al. Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice Journal of Diabetes Investigation 5 1 2014 31 37
29. M. Polydefkis, P. Hauer, S. Sheth, M. Sirdofsky, J.W. Griffin, and J.C. McArthur The time course of epidermal nerve fibre regeneration: Studies in normal controls and in people with diabetes, with and without neuropathy Brain 127 2004 1606 1615
30. R. Pop-Busui What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes Journal of Cardiovascular Translational Research 5 2012 463 478
31. K.P. Ratzmann, M. Raschke, I. Gander, and E. Schimke Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes The Journal of Diabetic Complications 5 1 1991 1 5
32. A.G. Smith, and J.R. Singleton Idiopathic neuropathy, prediabetes and the metabolic syndrome Journal of Neurological Sciences 242 1-2 2006 9 14
33. A.G. Smith, and J.R. Singleton Impaired glucose tolerance and neuropathy The Neurologist 14 1 2008 23 29
34. V. Spallone, D. Ziegler, R. Freeman, L. Bernardi, S. Frontoni, R. Pop-Busui, and et al. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management Diabetes/Metabolism Research and Reviews 27 2011 639 653
35. S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, and et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 33 2010 2285 2293
36. L. Vileikyte, M. Peyrot, C. Bundy, R.R. Rubin, H. Leventhal, P. Mora, and et al. The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument Diabetes Care 26 2003 2549 2555
37. H. Yamamoto, C.E. Lee, J.N. Marcus, T.D. Williams, J.M. Overton, M.E. Lopez, and et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons Journal of Clinical Investigation 110 2002 43 52
38. B. Yusta, L.L. Baggio, J.L. Estall, J.A. Koehler, D.P. Holland, H. Li, and et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress Cell Metabolism 4 2006 391 406